Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eli Lilly: Poised to Reward Patient Investors?
Eli Lilly: Poised to Reward Patient Investors?
Eli Lilly: Poised to Reward Patient Investors?
Submitted by
admin
on July 19, 2011 - 10:15am
Source:
Seeking Alpha
News Tags:
Eli Lilly
investors
Abbott Laboratories
AstraZeneca
Bristol-Myers Squibb
Forest Labs
Impax
Mylan
Teva Pharmaceuticals
Watson Pharmaceuticals
Headline:
Eli Lilly: Poised to Reward Patient Investors?
Do Not Allow Advertisers to Use My Personal information
